We then tested if the elevated α-KG could mediate the therapeutic effect of IDH2 inhibition in animals, using the cell-permeable compound DM-α-KG for the treatment of mice bearing MDA-MB-231 tumor xenografts. The gene discussed is IDH2; the disease is neoplasm.